Devices & Neurotechnology
Details checkedStrong evidenceCheckedcompany

Jabra Enhance Select 300

Also known as: Enhance Select 300, Jabra Enhance Select 300R, SoundScape

Jabra Enhance

Primary source
Company
Jabra Enhance
Program Type
Device
Modality
Hearing Aid/Software
Stage
Marketed
Status
Marketed
Target Gene
Route / Mode
External wearable OTC hearing aids plus mobile app and virtual audiology support
Confidence
85%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-06-10
Geography
United States
Population
adult, age-related, mild-moderate, post-lingual
Trial IDs
0
Mechanism

OTC receiver-in-ear hearing aids with SoundScape noise reduction, remote audiology services, mobile app adjustment, and Bluetooth calling features.

Indications
Notes

Adds Jabra’s mid-tier premium OTC device so the GN/Jabra line is not represented only by the current Select 700 flagship.

Evidence & Sources
3 structured sources
company
Supports: canonicalName, aliases, company, mechanism, status, route
Open
company
Supports: notes, programType, modality
Open
publication
Supports: notes
Open
Related Programs